Real-life comparison of three intravitreal antibiotic drug regimens in endophthalmitis

Real-life comparison of three intravitreal antibiotic drug regimens in endophthalmitis

Purpose: Real-life comparison of three intravitreal drug regimens used in cases of endophthalmitis at a tertiary care center in India. Methods: In this prospective, comparative study, patients of bacterial endophthalmitis were grouped according to intravitreal antibiotic drug regimens into Group 1 (...

Full description

Bibliographic Details
Main Authors:	Aafreen Bari, Rohan Chawla, Deepanshi Mishra, Ujjwalkumar Das, Nasiq Hasan, Gita Satpathy, T Velpandian, Shorya V Azad, Pradeep Venkatesh, Rajpal Vohra, Atul Kumar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	Indian Journal of Ophthalmology
Subjects:	ceftazidime endophthalmitis imipenem piperacillin/tazobactam vancomycin
Online Access:	http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=5;spage=1696;epage=1700;aulast=Bari

Similar Items

Intravitreal piperacillin-tazobactam in endophthalmitis caused by Mycobacterium abscessus in silico ne-filled eye: A case report
by: G Suganeswari, et al.
Published: (2020-01-01)

Clinical and bacteriological outcome of combined intravitreal injection of vancomycin and ceftazidime in experimentally induced endophthalmitis
by: Salah A Mady, et al.
Published: (2016-01-01)

Lowered Risk of Nephrotoxicity through Intervention against the Combined Use of Vancomycin and Tazobactam/Piperacillin: A Retrospective Cohort Study
by: Kazutaka Oda, et al.
Published: (2021-09-01)

Superinfection rate among the patients treated with carbapenem versus piperacillin/tazobactam: Retrospective observational study
by: Hessa Al Muqati, et al.
Published: (2021-03-01)

Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam
by: Chi-Hao Shao, et al.
Published: (2022-01-01)

Evaluating the appropriateness of carbapenem and piperacillin-tazobactam prescribing in a tertiary care hospital in Saudi Arabia
by: Nada A Alsaleh, et al.
Published: (2020-11-01)

Comparative Risk of Acute Kidney Injury Following Concurrent Administration of Vancomycin with Piperacillin/Tazobactam or Meropenem: A Systematic Review and Meta-Analysis of Observational Studies
by: Abdulmajeed M. Alshehri, et al.
Published: (2022-04-01)

Piperacillin–Tazobactam Plus Vancomycin-Associated Acute Kidney Injury in Adults: Can Teicoplanin or Other Antipseudomonal Beta-Lactams Be Remedies?
by: Abdullah Tarık Aslan, et al.
Published: (2022-08-01)

Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis
by: Jennifer M. Sim, et al.
Published: (2016-02-01)

Evaluating the Nephrotoxicity of Area-under-the-Curve-Based Dosing of Vancomycin with Concomitant Antipseudomonal Beta-Lactam Antibiotics: A Systematic Review and Meta-Analysis
by: Chia-Yu Chiu, et al.
Published: (2023-03-01)

Drug Regimens of Novel Antibiotics in Critically Ill Patients with Varying Renal Functions: A Rapid Review
by: Julie Gorham, et al.
Published: (2022-04-01)

Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients
by: François Barbier, et al.
Published: (2023-07-01)

Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections
by: Helio S. Sader, et al.
Published: (2021-12-01)

Intravitreal linezolid in the management of vancomycin-resistant enterococcal endophthalmitis
by: Olufemi Emmanuel Babalola
Published: (2020-12-01)

Acute kidney injury in villous cancer patients treated with vancomycin and tazobactam/piperacillin
by: Kaori Nakatani, et al.
Published: (2022-08-01)

Acute kidney injury associated with concomitant use of vancomycin with piperacillin-tazobactam: a focused review and meta-analysis
by: Hatice Duygu Bas, et al.
Published: (2016-06-01)

Mechanisms of Piperacillin/Tazobactam Nephrotoxicity: Piperacillin/Tazobactam-Induced Direct Tubular Damage in Mice
by: Jihyun Yang, et al.
Published: (2023-06-01)

Is Piperacillin-Tazobactam an Appropriate Empirical Agent for Hospital-Acquired Sepsis and Community-Acquired Septic Shock of Unknown Origin in Australia?
by: Alice Gage-Brown, et al.
Published: (2022-05-01)

Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates
by: Angeliki Kontou, et al.
Published: (2023-06-01)

The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations
by: Abdullah Tarık Aslan, et al.
Published: (2022-02-01)

Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility
by: Anthony Martin Mena, et al.
Published: (2023-08-01)

Assessment of knowledge, attitude, and practices of acute kidney injury incidence with co-administration of piperacillin/tazobactam and vancomycin among healthcare workers: A cross-sectional study
by: Haytham A. Wali, et al.
Published: (2023-06-01)

What to Do with the New Antibiotics?
by: Khalil Chaïbi, et al.
Published: (2023-03-01)

Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
by: David Busse, et al.
Published: (2021-08-01)

Piperacillin/Tazobactam-Induced Neutropenia: A Case Report
by: Hayati DEMİRASLAN, et al.
Published: (2012-03-01)

Acute kidney injury associated with piperacillin-tazobactam versus other antibiotics combined with vancomycin in critically ill patients: A retrospective cohort study
by: Masaad S. Almutairi, et al.
Published: (2023-12-01)

Targeted metagenomics using next generation sequencing in laboratory diagnosis of culture negative endophthalmitis
by: Deepanshi Mishra, et al.
Published: (2021-04-01)

Endophthalmitis caused by Kocuria kristinae: A Case Report
by: M. Alles, et al.
Published: (2020-10-01)

Response to comments on: Real-life comparison of three intravitreal antibiotic drug regimens in endophthalmitis
by: Aafreen Bari, et al.
Published: (2022-01-01)

Impact of extended-infusion piperacillin-tazobactam in a Canadian community hospital
by: April J. Chan, et al.
Published: (2023-03-01)

Susceptive piperacillin-tazobactam-induced Evans syndrome after radical resection of esophageal cancer: A rare case report
by: Yan Li, et al.
Published: (2023-12-01)

Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn
by: Daniel J. Selig, et al.
Published: (2022-05-01)

Simple HPLC-UV Method for Piperacillin/Tazobactam Assay in Human Plasma
by: Khaled Abdelkawy, et al.
Published: (2023-02-01)

The effect of meropenem versus piperacillin-tazobactam in critically ill patients with sepsis and septic shock
by: Yang Sun, et al.
Published: (2023-06-01)

Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature
by: Musa Alzahrani, et al.
Published: (2018-08-01)

A Case of DRESS Syndrome Associated with Piperacillin-Tazobactam Treatment and Literature Review
by: Seven ULUDOKUMACI, et al.
Published: (2012-12-01)

Galactomannan detection from piperacillin-tazobactam brands available in the Brazilian market
by: Melissa Orzechowski Xavier, et al.

Risk Factors of Death in Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacterales in Patients with Neoplasia
by: Cunha Ferreira T, et al.
Published: (2021-08-01)

Analysis of antibiotics discontinuation during bone marrow suppression in childhood, adolescent and young adult patients with febrile neutropenia
by: Ryoji Kobayashi, et al.
Published: (2021-12-01)

Effect of low-concentration vancomycin injection in the anterior chamber for prevention of infectious endophthalmitis after cataract surgery
by: TAO Li, et al.
Published: (2020-10-01)